Clinical Trial Update: Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study [NA]

View source ↗

Summary

A multicenter, randomized, open-label trial comparing tegoprazan dual therapy with a furazolidone-based bismuth quadruple regimen for Helicobacter pylori eradic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Furazolidone (furazolidone)
• Tegoprazan (tegoprazan)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Helicobacter Pylori Infection, Tegoprazan | NA | Status: COMPLETED